AI-generated summary
The authors studied transcranial photobiomodulation, a form of red or near-infrared light therapy, in rats with an ischemic stroke induced by photothrombosis. They report that light treatment was associated with a smaller lesion volume, altered astroglial and microglial markers, and lower levels of some inflammatory cytokines. The study was conducted in an animal model, so the findings may not apply directly to people.
- Who or what was studied
- Wistar rats with photothrombosis-induced ischemic stroke
- Limits stated in the abstract
- The study was conducted in an in vivo animal model and the abstract does not report the number of animals per group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Stroke, Photobiomodulation, Neuroinflammation, Laser, Low-level laser therapy, Transcranial photobiomodulation, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.